Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Beneficiation in Mining- Transforming Iron Ore for a Sustainable Future Business
  • Nikii Daas owns the Sachin Tendulkar-led Indian Legends franchise in Road Safety World Series Season 2 Press Release
  • BITICA Digital Crypto Currency Smart Staking Pool Launching On 13/01/2022 Business
  • 20th Mumbai Inter-school Kudo Tournament caps two decades of sporting excellence Press Release
  • Kaushalya Logistics Appoints Industry Veteran Mr. Rajendra Singh Shekhawat as Chief Executive Officer Business
  • SSO Cancer Hospital Calls for Urgent Action on Lung Health This World Lung Day Health
  • Meet Moutusi Sardar (YASHILA)– An Actor-Model From Kolkata Making It Big In The Music & Entertainment Industry Business
  • The Stars Don’t Just Shine. They Speak. Astro Hemant is Helping the World Listen Again Lifestyle

Akums Drugs receives EU GMP approval for two Haridwar-based manufacturing plants

Posted on July 11, 2022 By

Akums Drugs & Pharmaceuticals Ltd. has recently received European Union GMP approval for two of their manufacturing units in Haridwar.

New Delhi (India), July 11: Akums Drugs & Pharmaceuticals Ltd., the leading contract manufacturing pharmaceutical company in India, has recently acquired the stringent European Union (EU) GMP  approval for two of their manufacturing units in Haridwar. Following this prestigious nod, the gateway for several new opportunities in the European and other stringent regulatory markets is open to Akums Drugs. This move is another assent to Akums’ “Quality First” approach to work, which has now been endorsed by the EU -GMP beside all top-notch Indian and multinational pharmaceutical companies, who are already Akums’ long-standing partners.

Akums has received EU GMP approval for its two manufacturing plants. One plant manufactures solid oral dosage forms such as tablets, hard gelatin capsules, powders in sachets, etc. belonging to the general category, and Another plant manufactures large volume parenteral and small volume parenterals lines, including vials, ampoules, eyedrops, FFS  as well as for dry powder injections in the penicillin line.

Founder, Promoter and Director, Akums Drugs & Pharmaceuticals, Shri Sandeep Jain, says, “We are happy to announce that Akums Drugs has received EU GMP approval for two of our Haridwar-based manufacturing facilities, thus paving the path for new opportunities from the entire European Union as well as many other regulatory markets. We are already the largest Indian contract manufacturing company, manufacturing > 12% of country’s domestic supply, but what makes us happiest is being recognised for our “Quality First” approach. While we have been endorsed for this quality by our partners, who are also leading Indian and multinational pharmaceutical companies, the latest one from the EU GMP is very widely recognised & accepted. Congratulations to the entire team, and I hope this is the beginning of numerous possibilities for us.”

Founder, Promoter and Director Akums Drugs & Pharmaceuticals, Shri Sanjeev Jain, says, “Akums is already exporting to over 50 countries worldwide. With the esteemed EU GMP nod, we have now gained access to the most stringent global pharmaceutical markets besides the USA. These include the entire European Union, other markets like South Africa, Canada, Malaysia, Indonesia, Thailand, Australia/New Zealand and most middle-eastern countries. Since the EU GMP is their gold standard, we are welcome to cater to the pharmaceutical demands of all these geographies. With a large R&D infrastructure already in place, we are well equipped with a good basket of Products in our pipeline to expand our presence in these regulated markets. While we are extremely proud and excited to expand our presence in these markets, the Indian domestic market has always been our pride & passion and will continue to be so. The trust our partners have in us, and our Quality is paramount for us. ”

Akums Drugs & Pharmaceuticals Ltd. is India’s largest contract manufacturing pharmaceutical company, manufacturing more than 12% of India’s consumption. The organisation deals in manufacturing and exporting formulations in a broad spectrum of dosage forms & therapeutic segments. The company currently supplies to almost all Indian and multinational pharmaceutical companies across the globe and is the 67th largest employer in the country. The ten state-of-the-art facilities are dedicated to oral solid dosage forms (with separate units for beta lactum and non-beta lactum formulations), Oral liquid dosage forms, Sterile dosage forms (injectable, eye, ear & nasal), hormonal (oral and injectable), ointments & cosmetics, personal care,  Ayurvedic, food supplements & nutraceuticals and animal health care.

In a few years, the organisation has become the icon of the Indian pharmaceutical manufacturing industry and currently manufactures more than 12% of the country’s total medicinal requirements. With creme-de-la-creme of dedicated pharmaceutical personnel and standardised practices, Akums has been successful in attaining national and international accreditations and building trust-based on efficacy, safety & quality. The organisation is certified with WHO-GMP, ISO 9001:2015, ISO 14001:2015 certificates and various international accreditations, like; ANVISA, Brazil, NAFDAC, Nigeria, FDB, Ghana, PMPB, Malawi, amongst others and exports to 53 countries across the world.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business Tags:Business

Post navigation

Previous Post: KPar Smart Products Announces 1 year report on Smart Cities
Next Post: La Excellence announced the launch of its Batch-2 for students aspiring to enter into the Civil Services in Telangana on July 11

Related Posts

  • EDUCATING THE MARKET Initiative by Yield 4 Finance (Y4F) Business
  • White Flower Developers announces new project ” The Cove” launch in Naraina Phase-2 New Delhi, India Business
  • Praveg Limited 9M FY23 PAT up 208% Business
  • How EZ Legal Hire is Transforming Access to Legal Services in the UAE Business
  • Sachin Salunkhe Leads India’s Pioneering Role in Global Fintech Evolution at ICION Fest Business
  • Commodity trading gains momentum – by Sidhavelayutham, CEO & Founder, Alice Blue Business

Recent Posts

  • Why Home Loan Borrowers Can No Longer Trust a Single Recommendation
  • Fabtech’s Wholly Owned Subsidiary Secures AED 9.92 Million Turnkey Flavour Manufacturing Project in UAE
  • Mira Mediterranean Leads the Top 5 Hottest Hookah Lounges in New York City in 2026
  • Team Computers on the Future of Marketing: When AI Runs the Campaign, What Is Left for Marketers?
  • Personal Loan in India: A Comparison Guide


Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • How the High Net Worth Individuals of the Chennai Elites handled their Wealth with Family Office Services during Pandemic Business
  • Zero Footmarks, India’s first footwear project that creates value for used footwear, launched in Kerala Business
  • Esha Soni and Keshav Agrawal Unveil Atalchatra’s HarmoniXchange: A Game-Changer in Music Distribution Lifestyle
  • NCPA Mumbai and National Theatre UK Present Connections India’s Third Edition for Youth Theatre Entertainment
  • Magellanic Cloud’s Subsidiary IVIS Secures Letter of Intent from Manappuram Finance for AI-Powered E-Surveillance across ~1,000+ Branches Business
  • IIA Young Architects Festival And YAF Awards 2022 Will Be Held In Calicut Along With Crossroads Business
  • Luxury French furniture brand Ligne Roset opens its first exclusive store in India, in association with Burgundy Brand Collective Business
  • Focus Lighting Q3FY23 Net profit up 760% Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme